How can we help you?

The TSJCI CaRes Seminar Series runs throughout the year and brings together clinical and scientific perspectives on key areas and themes in cancer. Each seminar takes a two-pronged approach, with presentations exploring the topic from both a clinical and scientific perspective. The series aims to showcase the latest innovations and developments in cancer research and clinical care..

Wednesday, 7 October 2026

  • Prof Larry Bacon – CAR-T Cell Clinical Programme
  • Hayley Foy-Stones – Immune Reconstitution and CAR T Cell Therapy

Wednesday, 24 June 2026

  • Dr Ann Marie Duff – Biological Reclassification of Post-Oesophagectomy Pneumonia: A Precision Framework for Clinical Decision-Making
  • Prof Joanne Lysaght – Targeting the Tumour Microenvironment to Improve Immunotherapy Response Rates

Tuesday, 9 June 2026

  • Prof Stephen Maher – The Resistant Cell: Unpicking Cancer's Escape Mechanisms
  • Lorraine Smith – Investigating the Therapeutic Potential of Irreversible Electroporation for Barrett's Oesophagus

Tuesday, 12 May 2026

  • Dr Mark Ward – Liquid Biopsy and Systemic Therapies: Exploring CTCs, ctDNA, and Fragmentomics
  • Dr Jessie Elliott – Post-Treatment Surveillance in Oesophagogastric Cancer

Wednesday, 29 April 2026

  • Dr Lucy Norris – Mechanisms of Treatment-Associated Thrombosis in Cancer Patients
  • Prof Feras Abu Saadeh – Prediction and Prevention of Thrombosis Post Gynaecological Cancer Surgery

Wednesday, 25 March 2026

  • Dr Emily Harrold – The Evolving Landscape of Systemic Therapy for HCC

Tuesday, 10 March 2026

  • Dr Maitiú Ó Murchú – Developing a Translational Head and Neck Cancer Research Programme
  • Mr Conall Fitzgerald – Fundamentals in Head and Neck Cancer Surgery

Wednesday, 28 January 2026

  • Prof Gerry Hanna – Unmet Needs in Lung Cancer Radiotherapy
  • Prof Michelle Leech – Optimising Radiation Therapy Outcomes

Tuesday, 13 January 2026

  • Prof Patrick Forde – Immune Checkpoint Blockade in Resectable Thoracic Cancers
  • Dr Christina Cahill – Patient-Derived Lung Cancer Organoids for Precision Medicine